ACHE and dementia: Rivastigmine, an inhibitor of both acetylcholinesterase and butyrylcholinesterase, produced a moderate but significant improvement in global ratings of dementia, cognition with measurements of executive functions and attention, and neuropsychiatric behavioural symptoms among patients with dementia associated with PD [52].